Prices as of 2025-11-21 16:20:42 ET
Ticker Appearances
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Your Weekly Roadmap
Stocks Pull Back Heading into Next CPI Release
Good evening, Fundstrat Head of Research Tom Lee has repeatedly told readers that we are in a “buy the dip” regime, and this week the...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Daily Technical Strategy
Medical Devices breakout should give Healthcare a further boost
I WILL NOT BE PUBLISHING FRIDAY, 4/21 DUE TO TRAVEL PLANS. THANK YOU FOR YOUR UNDERSTANDING. No evidence of any change of trend,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Your Weekly Roadmap
Stocks Pull Back Heading into Next CPI Release
Good evening, Fundstrat Head of Research Tom Lee has repeatedly told readers that we are in a “buy the dip” regime, and this week the...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Daily Technical Strategy
Medical Devices breakout should give Healthcare a further boost
I WILL NOT BE PUBLISHING FRIDAY, 4/21 DUE TO TRAVEL PLANS. THANK YOU FOR YOUR UNDERSTANDING. No evidence of any change of trend,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 2 free reports this month.
Visitor: 74d514-a8e8e8-8bddc7-e2401b-51dde6 Array ( [cookie] => 74d514-a8e8e8-8bddc7-e2401b-51dde6 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.157 )
